Itopride and pantoprazole outcomes in diabetic gastroparesis trial (IPOD trial).
J Indian Med Assoc
;
2008 Dec; 106(12): 814-5
Artículo
en Inglés
| IMSEAR
| ID: sea-96333
ABSTRACT
The most common cause of gastroparesis is diabetes mellitus. The present study was carried out to asses the combination of itopride and pantoprazole in the treatment of diabetic gastroparesis. The study was an open label, multicentre, conducted in 743 patients with diabetic gastroparesis for a period of 3 weeks. The efficacy parameters included nausea, vomiting, early satiety, bloating, postprandial fullness, epigastric pain and regurgitation. The patients were evaluated based on the frequency and severity of symptoms and compared with the baseline scores. There were significant improvement in severity as well as the frequency of all the symptom parameters of the disease (p<0.001). The physicians' evaluation to the therapy was rated either excellent or good.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Benzamidas
/
Compuestos de Bencilo
/
Índice de Severidad de la Enfermedad
/
Fármacos Gastrointestinales
/
Anciano
/
Humanos
/
Adolescente
/
Resultado del Tratamiento
/
Gastroparesia
/
Adulto
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
J Indian Med Assoc
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS